Medical Advisors:

 

Thomas Bauer, MD, is Chief of Thoracic Surgery at the Helen F. Graham Cancer Center, Christiana Care Health System, in Newark, Delaware, and Principal Investigator of the Biomoda Phase II clinical trial currently underway.  He is also a clinical assistant professor of surgery at Jefferson Medical College and adjunct assistant professor of biological sciences at the University of Delaware.  He has lead several lung and esophageal cancer studies and heads up Christiana’s participation in the International Early Lung Cancer Action Program (I-ELCAP).  Dr. Bauer has authored dozens of peer- and nonpeer-reviewed publications and abstracts and serves on many committees and programs. 

Dan Merrick, MD, is known for his work in anatomic and clinical pathology, and molecular genetic pathology.  He has published several papers on lung cancer and is an expert on sputum cytology.  Dr. Merrick graduated from the University of Washington Medical School.   

Tim Kennedy, MD, is associated with the University of Colorado and specializes in internal medicine, pulmonology and cytopathology.  He is an expert in sputum cytology. Dr. Kennedy has authored many peer-reviewed publications, belongs to dozens of professional societies and serves on many committees.  He has held faculty positions at the University of Arizona and University of Colorado Health Sciences Center. 

Ramesh Gopal, MD, is a board-certified radiation oncologist serving as Medical Director of radiation treatment at the M.D. Anderson Cancer Center satellite at the Presbyterian Kaseman Hospital in Albuquerque, New Mexico. 

Lara Patriquin, MD, is a Principal Investigator for Biomoda’s Phase II clinical trial. Dr. Patriquin is a radiologist at Radiology Associates and Presbyterian Hospital in Albuquerque, New Mexico. 

Steve Groshong, MD, PhD, is a pathologist at the National Jewish Hospital in Denver and Assistant Professor at the University of Colorado, Denver.   

 

Clinical Advisors:

 

Richard Phillips MSPH, PhD is a Principal Consultant in Medical Device development at Quintiles Consulting.  He had four years of employment at FDA’s Office of Device Evaluation, serving as a first-line scientific reviewer in the Chemistry and Toxicology Branch, Division of Clinical Laboratory Devices, and then as Chief, Anesthesiology and Defibrillator Devices Branch, Division of Cardiovascular, Respiratory and Neurological Devices.  Before joining FDA, Dr. Phillips worked for three in vitro diagnostic device companies, serving each company in the capacity of Director of Clinical Research/Clinical Affairs. Dr. Phillips is a Diplomate of the American Board of Forensic Toxicology, and the author of numerous papers in clinical chemistry, analytical and forensic toxicology, and in vitro diagnostic devices.  He is a member of the American Association for Clinical Chemistry, Association of Clinical Scientists, Clinical Ligand Assay Society, Society of Forensic Toxicologists, and the American Academy of Forensic Sciences.  Dr. Phillips earned his BS in Biology and Chemistry from Marian University, Indianapolis, IN, his MSPH from Univ. of North Carolina, Chapel Hill, NC, and his Ph.D. from Indiana University, Bloomington, IN.

Richard Holcomb PhD is an Associate Senior Consultant with Quintiles.  Dr. Holcomb works with clients in the medical device, pharmaceutical, biologic, and biotechnology industries to develop and implement preclinical and clinical development plans, with special emphasis in medical devices regulated by the Food and Drug Administration (FDA).  Dr. Holcomb has a B.S. in Mathematics from Michigan Technological University, an M.S. and a Ph.D. in Biometry from the University of Minnesota.

Tom Zimmerman,  CRO Project Advisor with Alquest, Inc., has 25 years experience in clinical laboratory operations and management. He is an expert in laboratory logistics, data management, point-of-care issues, quality assurance and validation. Mr. Zimmerman has worked for Nichols Institute Reference Laboratories, SmithKline Beecham Clinical Laboratories, Focus Diagnostics, Medtox Laboratories, ViroMed Laboratories, and Mayo Medical Laboratories/Clinical Trial Services where he was senior analyst programmer and more recently Operations Administrator for Core Laboratory Services. Tom earned his BA from St Cloud State University in Minnesota

 

 

Home  ::  Company  ::  Technology  ::  Links  ::  Site Map  ::  Contact Us